Locator: 46636OZEMPIC.
Easy to read:
A bit harder to read because it includes a graph, a lot of numbers, and "P" thing:
Then, there was a lot of discussion about reasons for this increased in uterine mortality.
But this is what folks will note:
So, what's an investor to do? Two words.
Lilly. Ozempic.
The problem: Medicare doesn't cover Ozempic yet for weight loss.
But there's work-around: Medicare does cover Ozempic for type-2 diabetes. A much lower bar to meet.
But this is key. Minority women have highest risk and if Medicare doesn't cover Ozempic for obesity, one starts getting into racism.
So, it's just a matter of time. I think two years, possibly even as early as 2025.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.